Skip to content
Open access

FAIMS-GPF XL-MS: crosslinking-mass spectrometry based on gas-phase fractionation

May 2025 · bioRxiv · Vol 17 · 0 citations · 90 references
Medicine Biology

Abstract

Protein-protein interactions (PPIs) underpin nearly all cellular processes; therefore, mapping PPI and protein-protein association networks is critical for understanding how biological systems function in health and disease. However, many functionally relevant PPIs are transient and mediated by weak affinity interactions, making them challenging to detect. Using chemical cross-linking together with mass spectrometry (XL-MS) has emerged as an important category of methods for mapping PPIs, including those that are more dynamic and transient, although XL-MS workflows face limitations which hinder their routine use, especially in proteomic platforms. Here, to address these limitations, we developed a XL-MS workflow based on gas-phase fractionation (GPF) using high-field asymmetric waveform ion mobility spectrometry (FAIMS). Our optimized FAIMS-GPF XL-MS protocols exhibited improved performance when handling both low-complexity samples, such as purified Cdk7-Activating Kinase (CAK) heterotrimer, and high-complexity cross-linked HeLa lysates. In HeLa lysate, we identified 1,278 cross-links accounting for 213 PPIs without any in-solution fractionation, starting from less than 20 µg of sample. The method also proved effective for analyzing low-abundance, high-complexity samples such as spliceosomes. Overall, FAIMS-GPF enhanced the detection of cross-linked peptides and improved PPI coverage, thus offering a scalable, high-sensitivity solution for XL-MS integration with structural biology and functional proteomics applications.

Read PDF

Similar papers

Sep 2026

In Vivo Chemical Cross-Linking Coupled with Reversed-Phase Co-Fractionation Mass Spectrometry Enables Protein Complex Analysis

This strategy enables sensitive and physiologically relevant identification of protein complexes, offering a reliable approach for characterizing the composition of potential protein assemblies within specific biological systems.

Liu-Qing She, Wei Liu, Ming-Xia Gao et al. · 0 citations
Review Oct 2026

Emerging Roles of Mass Spectrometry-Based Proteomics in Drug Discovery.

Mass spectrometry (MS)-based proteomics has emerged as a versatile platform in modern drug discovery, enabling system-wide interrogation of protein abundance, posttranslational modifications (PTMs), turnover, structural stability, and interactions with small molecules in native biological contexts. In this review, we i...

Ka Yang, Wei-Ping Tang, Tao-Sheng Chen et al. · 0 citations
Open access Sep 2026

Background proteome correction promotes confident identification of dynamic protein-protein interactions between different biological contexts

It is shown that accurate representation of the bead background, which depends on the affinity matrix in use, is critical for elimination of false positive and false negative PPIs, as OGT PPI dynamics were measured under OGT catalytic inhibition via OSMI-4, which is known to perturb gene expression.

M. Brunelli, Lisa Morishita-Cartwright, Natalie M. Clark et al. · 0 citations
Open access Oct 2026

Optimizing nanoLC-TIMS-TOF and lipidomics sample preparation for low volume of plasma

The feasibility and practical scalability of positive ion nanoLC-TIMS-MS lipid profiling for sample-limited applications under the evaluated conditions support the feasibility and practical scalability of nanoflow liquid chromatography coupled with trapped ion mobility spectrometry and time-of-flight mass spectrometry.

Klidel Fae B. Rellin, L. Abel, Aiko Barsch et al. · 1 citation · ⚡1

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.